The risk for major adverse cardiovascular events decreased with tirzepatide vs. liraglutide and semaglutide in patients with ...

Major pharmaceutical companies facing patent cliffs and pipeline gaps may view Viking as an attractive acquisition target if ...

Ozempic face is one of the common side effects of Ozempic the weight loss drug that is primarily used to treat type 2 ...

The company raised the lower end of its full-year outlook to an adjusted earnings per share range of $12.95 to $13.05, up from $12.75 to $13.05. In the third quarter, Waters expects adjusted earnings ...

Guardian Australia has uncovered a new scam targeting people who are trying to lose weight. Crooks pose as famous dietitians ...

Innovent likely to post a first-half net profit of US$36.4 illion, and BeOne’s first-half net rofit is expected to come in at ...

INFLUENCER and YouTube star Tana Mongeau has issued a dramatic warning to fans after trying the weight loss jab Mounjaro. The US star, 26, says it left her crawling on the floor and feeling like ...

Caution is needed until the harms are better understood Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a promising treatment for obesity and diabetes. Over the past few years, ...

Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients — and President Trump is ...

Online weight-loss company Noom said on Monday it would sell copies of Novo Nordisk's Wegovy at an introductory price of $119 for up to a quarter of the branded drug's standard dose, giving patients a ...

With its new serum, the medical grade skin care brand is targeting laxity, which many weight loss drug users experience.

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are changing the weight loss game. But there’s a catch—and most people don’t hear about it until it’s too late. Yes, these medications suppress ...